Company Profile:
Company Introduction:
Biocon Limited is an innovation-led, fully integrated global biopharmaceutical company based in Bengaluru, India. It is a pioneer in the field of biosimilars and novel biologics, specializing in the development and manufacturing of affordable biotherapeutic products for diabetes, oncology, immunology, and other therapeutic areas. The company boasts extensive research and development capabilities, state-of-the-art manufacturing facilities, and a significant global presence, serving patients in over 120 countries. Its portfolio includes a range of biosimilars, branded formulations, and research services.
Classification: Manufacturer
Enterprise Products
Indian Bio-Tech companies produce or sell products such as biosimilars including recombinant insulin, erythropoietin, filgrastim, rituximab, trastuzumab; vaccines for various infectious diseases like polio, measles, rubella, hepatitis B, DPT, and COVID-19; diagnostic kits for infectious diseases, cancer, and other conditions, including PCR test kits, rapid antigen test kits, and ELISA kits; bio-fertilizers and bio-pesticides; genetically modified seeds such as Bt cotton; enzymes for industrial applications in sectors like textiles, food and beverage, and detergents; recombinant proteins and monoclonal antibodies; plant tissue culture products; contract research and manufacturing services for drug discovery, clinical trials, and biologics production; bioinformatics solutions and genomic sequencing services; blood glucose monitoring systems and related consumables; cell and gene therapy solutions; bioplastics and other bio-based chemicals; environmental biotechnology solutions including bioremediation products.